Elevated levels of APOA1 were found to be inversely associated with the prevalence of NAFLD, suggesting that increased APOA1 levels may offer a protective effect against the disease (11). This evidence concerns the gene APOA1 and metabolic dysfunction-associated steatotic liver disease.